-

Verily Health Selected to Build Data Platform for ARPA-H CIRCLE Program

Verily Pre will power CIRCLE’s shared database and AI-driven research tools to improve outcomes for critically ill patients

DALLAS--(BUSINESS WIRE)--Verily Health Inc., a precision health AI company, today announced it has been selected by the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services, to serve as an Acceleration Platform performer for the agency's Critical Illness Immunological Reprogramming and Control Point Learning Engine (CIRCLE) program. In this role, Verily Health will build and operate the shared program database that CIRCLE's research teams will use to train, validate, and refine tools aimed at giving ICU care teams a real-time window into patients' immune systems.

Verily Health was selected to build and operate the CIRCLE program database. Verily Workbench, part of the Verily Pre Platform, the company's flagship data and AI platform, will serve as the program’s secure database and research environment.

Share

ARPA-H recently announced the full slate of CIRCLE performers. CIRCLE is a five-year program working to give ICU clinicians real-time visibility into a patient's immune system so they can intervene before organ damage occurs. ARPA-H has set a program-wide goal of reducing average ICU length of stay by 25 percent.

"We're honored that ARPA-H selected Verily Health to build this program's data foundation. It reflects the trust federal researchers are placing in Verily Pre as a platform for complex, multi-institution science, and it's exactly the kind of opportunity that accelerates our vision to build a trusted foundation for healthcare," said Stephen Gillett, Chairman and CEO of Verily Health.

Verily Health's Role in CIRCLE

Verily Health was selected to build and operate the CIRCLE program database. Verily Workbench, part of the Verily Pre Platform, the company's flagship data and AI platform, will serve as the program’s secure database and research environment.

Verily Pre will ingest and harmonize public and private critical-illness datasets alongside data generated by the program's research teams for use in performer model training and validation. Verily Health will also generate data products intended to become resources for the broader critical care research community, giving researchers AI-powered search and discovery tools to explore the dataset rather than writing raw database queries.

This research was, in part, funded by the Advanced Research Projects Agency for Health (ARPA-H). The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the United States Government.

About Verily Health Inc.

Verily Health is a data platform and technology company purpose-built to power AI-enabled precision health solutions that accelerate research and improve care for individuals and communities. Uniquely positioned at the intersection of technology, data science, and healthcare, Verily Health transforms multimodal health data into insights, models, and actions that make healthcare more personalized, predictive, and precise. For more information about Verily Health please visit: verily.com.

Contacts

Media Contact:
Laurie Ferguson
VP Communications
verily-press@verily.com

Verily Health Inc.


Release Versions

Contacts

Media Contact:
Laurie Ferguson
VP Communications
verily-press@verily.com

More News From Verily Health Inc.

Verily Health Brings Its Vision for Secure Healthcare Intelligence to HLTH USA 2026

DALLAS--(BUSINESS WIRE)--Verily Health Inc. (“Verily Health”) is bringing its vision for healthcare data intelligence to HLTH USA 2026 with Verily Pre®, its Governed Health Intelligence platform. Verily Pre enables healthcare organizations to responsibly govern, model and securely activate protected health data at scale, with the scientific rigor, oversight and auditability needed to support trusted health insights. “The industry doesn’t lack health data; it needs a trusted way to turn that dat...

Verily Health and Autoimmune Registry Partner to Build Cross-Disease Research Infrastructure for Autoimmune Conditions

DALLAS--(BUSINESS WIRE)--Verily Health Inc., a healthcare data intelligence company, today announced a strategic partnership with Autoimmune Registry Inc. (ARI), a nonprofit nominated for the inaugural 2026 Prix Galien Patient First Award in Honor of Michael J. Fox for its work studying autoimmune diseases, the populations they affect, and how they co-occur and progress over time. Through the partnership, Verily Health will provide the patient engagement, research infrastructure, and analytics n...

Verily Health Awarded Centers for Disease Control and Prevention Contract to Support National Infectious Disease Wastewater Surveillance

DALLAS--(BUSINESS WIRE)--Verily Health Inc., a healthcare data intelligence company, announced today that it has been awarded a contract by the Centers for Disease Control and Prevention (CDC) to continue supporting the national wastewater-based infectious disease surveillance program, building on the work that the company has performed for the CDC since 2023. Under the new award, Verily Health will support CDC's National Wastewater Surveillance System through Verily Sightline, combining wastew...
Back to Newsroom